Akèy › Kadiyomiopati Ipertrofik › Massachusetts › Boston
Etid klinik pou Kadiyomiopati Ipertrofik nan Boston, MA
6 etid pou Kadiyomiopati Ipertrofik ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Ap rekriteEtid obsèvasyon
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Ap rekriteFaz 2
- Imbria Investigational Site, Boston
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Ap rekriteFaz 2
- Boston Children's Hospital, Boston
HCMR Re-Imaging Study
Ap rekriteEtid obsèvasyon
- Brigham & Women's Hospital, Boston
Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
Ap rekriteEtid obsèvasyon
- Analysis Group Inc., Boston
Etid Kadiyomiopati Ipertrofik nan lòt vil
- Cleveland, OH4 etid
- Charlottesville, VA4 etid
- San Francisco, CA4 etid
- Chicago, IL3 etid
- New York City, NY3 etid
- Plano, TX3 etid
- Charlotte, NC3 etid
- Houston, TX3 etid
- San Diego, CA3 etid
Lòt etid nan Boston
- Kansè nan tete112 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)85 etid
- Kansè Metastatik63 etid
- Kansè kolorektal63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.